Created at	Source	Raw Value	Validated value
March 11, 2023, 8 p.m.	usa	Neutralization GMTR SARS-CoV-2 pseudovirus;Seroconversion Neutralization GMT SARS-CoV-2 pseudovirus;Severe adverse events;Solicited and unsolicited adverse reactions;Unsolicited adverse reactions	Neutralization GMTR SARS-CoV-2 pseudovirus;Seroconversion Neutralization GMT SARS-CoV-2 pseudovirus;Severe adverse events;Solicited and unsolicited adverse reactions;Unsolicited adverse reactions
May 21, 2022, 9:30 a.m.	usa	GMT against SARS-CoV-2 (ELISA);Neutralization GMTR SARS-CoV-2 pseudovirus;Severe adverse events;Solicited and unsolicited adverse reactions;Unsolicited grade >2 adverse reactions	GMT against SARS-CoV-2 (ELISA);Neutralization GMTR SARS-CoV-2 pseudovirus;Severe adverse events;Solicited and unsolicited adverse reactions;Unsolicited grade >2 adverse reactions
May 1, 2022, 3:30 a.m.	usa	GMT against SARS-CoV-2 (ELISA);Neutralization GMTR SARS-CoV-2 pseudovirus;Severe adverse events;Solicited adverse reactions;Unsolicited grade >2 adverse reactions	GMT against SARS-CoV-2 (ELISA);Neutralization GMTR SARS-CoV-2 pseudovirus;Severe adverse events;Solicited adverse reactions;Unsolicited grade >2 adverse reactions